[ Price : $8.95]
An opinion article calls on FDA to establish a formal regulatory framework for evaluating vaccines as potential interventions to p...[ Price : $8.95]
Merck says FDA has approved an expanded indication for its pneumococcal conjugate vaccine, Capvaxive, allowing its use in children...[ Price : $8.95]
FDA approves a Beam Therapeutics IND for BEAM-304, allowing the company to begin clinical testing of its experimental base-editing...[ Price : $8.95]
FDA approves the first generic version of Xofluza (baloxavir marboxil), clearing Norwich Pharmaceuticals' generic tablets for the ...[ Price : $8.95]
The FDA Vaccines and Related Biological Products Advisory Committee votes to support Moderns mRNA flu vaccine mFlusiva.[ Price : $8.95]
HHS says FDA is seeking labeling changes for testosterone replacement therapy products to reflect current scientific and clinical ...[ Price : $8.95]
FDA posts an unusual internal memorandum detailing how former CDER acting director Tracy Beth Hoeg opposed approval of a Sanofi su...[ Price : $8.95]
Grace Therapeutics says it plans to resubmit its NDA for GTx-104 after receiving an FDA Complete Response Letter in April.